Keywords
Lipid profile
Dylsipidemia
Weight loss
Cohort study
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To analyze the association between obesity and lipid profile in patients followed in a retrospective cohort study. Methods: An analytical observational study based on electronic medical records of 216 adults with obesity hospitalized for treatment at a specialized hospital in Bahia, Brazil, between 2016 and 2022. Anthropometric measurements, body composition, and lipid profile parameters (total cholesterol, LDL-c, HDL-c, and triglycerides) were assessed at hospital admission and discharge. Paired statistical tests were applied, with a significance level of 5%. Results: Significant reductions were observed in body weight, body mass index, fat mass, body fat percentage, and waist-to-hip ratio (p < 0.001). Improvements in lipid profile were also identified, with significant reductions in triglycerides, total cholesterol, and LDL-c levels (p < 0.001), while HDL-c levels remained stable. Conclusion: Weight loss achieved during hospital-based treatment was associated with significant improvements in anthropometric parameters and lipid profile, highlighting the relevance of structured obesity management strategies for cardiovascular risk reduction.
References
AMERICAN DIABETES ASSOCIATION. Standards of care in diabetes—2024. Diabetes Care, 2024; 47(Suppl 1): S1–S350.
DE ANDRADES CDS, et al. Prevalence of dyslipidemia, atherogenic and cardiovascular risk in overweight and obese adolescents. Journal of Pediatric Endocrinology and Metabolism, 2023; 36(4): 453–460.
BAYS HE, et al. Obesity, dyslipidemia, and cardiovascular disease: a joint expert review from the Obesity Medicine Association and the National Lipid Association. Obesity Pillars, 2024; 10: 100108.
BJORNSTAD P, ECKEL RH. Pathogenesis of lipid disorders in insulin resistance: a brief review. Current Diabetes Reports, 2018; 18(12): 127.
BOREN J, et al. Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia. Nature Reviews Cardiology, 2022; 19(9): 577–592.
BRASIL. Ministério da Saúde. Vigitel Brasil 2024: vigilância de fatores de risco e proteção para doenças crônicas por inquérito telefônico. Brasília: Ministério da Saúde, 2024. Disponível em: https://www.gov.br/saude. Acessado em: 09 de outubro de 2025.
DATTILO AM, KRIS-ETHERTON PM. Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. American Journal of Clinical Nutrition, 1992; 56(2): 320–328.
FEINGOLD KR. Obesity and dyslipidemia. Endotext, 2023.
FRANZ MJ, et al. Weight-loss outcomes: a systematic review and meta-analysis of clinical trials. Journal of the American Dietetic Association, 2007; 107(10): 1755–1767.
JENSEN MD, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults. Circulation, 2014; 129(25 Suppl 2): S102–S138.
KHAN MA, et al. Environmental and behavioral determinants of obesity. Obesity Reviews, 2022; 23(4): e13401.
KIM JH, et al. Obesity and lipid abnormalities in longitudinal cohorts. Atherosclerosis, 2024; 384: 1–9.
NCD RISK FACTOR COLLABORATION (NCD-RISC). Worldwide trends in underweight and obesity from 1990 to 2022. The Lancet, 2024; 403(10431): 1027–1050.
NOWICKA P. Obesity as a chronic disease: mechanisms and implications. Nature Reviews Endocrinology, 2024; 20(3): 145–158.
ORGANIZAÇÃO MUNDIAL DA SAÚDE. Obesity and overweight. Geneva: World Health Organization, 2022. Disponível em: https://www.who.int. Acessado em: 02 de outubro de 2025.
POOBALAN A, et al. Effects of weight loss in overweight and obese individuals: systematic review. Obesity Reviews, 2004; 5(1): 43–50.
SARIN S, et al. HDL functionality rather than HDL cholesterol levels as a marker of cardiovascular risk. Atherosclerosis, 2019; 282: 1–7.
THEODORE RF, et al. Effects of calorie restriction on lipid profile in individuals with metabolic syndrome. Journal of Nutrition, 2007; 137(6): 1403–1409.
VEKIĆ J, et al. Obesity and dyslipidemia. Metabolism, 2019; 92: 71–81.
WELSH JA, et al. Global trends in obesity and overweight. The Lancet Diabetes & Endocrinology, 2024; 12(2): 120–132.
WING RR, et al. Benefits of modest weight loss in improving cardiovascular risk factors. Diabetes Care, 2011; 34(7): 1481–1486.
WORLD OBESITY FEDERATION. World Obesity Atlas 2025. London: World Obesity Federation, 2025. Disponível em: https://www.worldobesity.org. Acessado em: 08 de outubro de 2025